260 related articles for article (PubMed ID: 23150190)
1. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
[TBL] [Abstract][Full Text] [Related]
2. Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases.
Matuskova M; Kozovska Z; Toro L; Durinikova E; Tyciakova S; Cierna Z; Bohovic R; Kucerova L
J Exp Clin Cancer Res; 2015 Apr; 34(1):33. PubMed ID: 25884597
[TBL] [Abstract][Full Text] [Related]
3. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
4. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
[TBL] [Abstract][Full Text] [Related]
5. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.
Kucerova L; Skolekova S; Demkova L; Bohovic R; Matuskova M
Gene Ther; 2014 Oct; 21(10):874-87. PubMed ID: 25056607
[TBL] [Abstract][Full Text] [Related]
7. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine.
Lawrence TS; Rehemtulla A; Ng EY; Wilson M; Trosko JE; Stetson PL
Cancer Res; 1998 Jun; 58(12):2588-93. PubMed ID: 9635583
[TBL] [Abstract][Full Text] [Related]
8. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
[TBL] [Abstract][Full Text] [Related]
9. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.
Nouri FS; Wang X; Hatefi A
J Control Release; 2015 Feb; 200():179-87. PubMed ID: 25575867
[TBL] [Abstract][Full Text] [Related]
11. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
[TBL] [Abstract][Full Text] [Related]
12. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
13. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
Altanerova U; Jakubechova J; Benejova K; Priscakova P; Repiska V; Babelova A; Smolkova B; Altaner C
Int J Cancer; 2021 Jan; 148(1):128-139. PubMed ID: 32621791
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma.
Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY
Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135
[TBL] [Abstract][Full Text] [Related]
16. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
17. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
[TBL] [Abstract][Full Text] [Related]
18. Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes.
Denning C; Pitts JD
Hum Gene Ther; 1997 Oct; 8(15):1825-35. PubMed ID: 9358032
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy.
Boucher PD; Im MM; Freytag SO; Shewach DS
Cancer Res; 2006 Mar; 66(6):3230-7. PubMed ID: 16540675
[TBL] [Abstract][Full Text] [Related]
20. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells.
Yang L; Chiang Y; Lenz HJ; Danenberg KD; Spears CP; Gordon EM; Anderson WF; Parekh D
Hum Gene Ther; 1998 Mar; 9(5):719-28. PubMed ID: 9551619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]